These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37686099)

  • 1. Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients.
    Escuin D; López-Vilaró L; Bell O; Mora J; García-Valdecasas B; Moral A; Clos M; Boronat L; Arqueros C; Barnadas A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases.
    Escuin D; López-Vilaró L; Mora J; Bell O; Moral A; Pérez I; Arqueros C; García-Valdecasas B; Ramón Y Cajal T; Lerma E; Barnadas A
    Front Oncol; 2021; 11():627811. PubMed ID: 34513655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.
    Sun D; Zhong J; Wei W; Chen X; Liu J; Hu Z
    J Gene Med; 2019 Apr; 21(4):e3075. PubMed ID: 30716792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
    Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
    Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer.
    Escuin D; López-Vilaró L; Bell O; Mora J; Moral A; Pérez JI; Arqueros C; Ramón Y Cajal T; Lerma E; Barnadas A
    Front Genet; 2020; 11():562114. PubMed ID: 33343622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients.
    Escuin D; Bell O; García-Valdecasas B; Clos M; Larrañaga I; López-Vilaró L; Mora J; Andrés M; Arqueros C; Barnadas A
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
    Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
    J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.
    Foekens JA; Sieuwerts AM; Smid M; Look MP; de Weerd V; Boersma AW; Klijn JG; Wiemer EA; Martens JW
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13021-6. PubMed ID: 18755890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
    Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
    World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis.
    Qattan A; Al-Tweigeri T; Alkhayal W; Suleman K; Tulbah A; Amer S
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-based microRNA signatures in early diagnosis of breast cancer.
    Li X; Zou W; Wang Y; Liao Z; Li L; Zhai Y; Zhang L; Gu S; Zhao X
    Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical risk analysis of non-visualized sentinel lymph node in breast cancer.
    Zhang J; Pei J; Liu H
    Cancer Biomark; 2018; 23(2):179-183. PubMed ID: 30198862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
    Chen B; Zhang G; Lai J; Xiao W; Li X; Li C; Mok H; Li K; Wang Y; Cao L; Jia M; Ren C; Wen L; Wei G; Lin J; Li Y; Zhang Y; Chen X; Wu X; Zhang H; Li M; Liu J; Balch CM; Liao N
    EBioMedicine; 2021 Sep; 71():103542. PubMed ID: 34454403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.